|
?:abstract
|
-
The coronavirus disease-2019 (COVID-19) has been designated as a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since December 2019, when an outbreak of pneumonia cases emerged in Wuhan, China The COVID-19 pandemic has led to a global health crisis, devastating the social, economic and political aspects of life Many clinicians, health professionals, scientists, organizations, and governments have actively defeated COVID-19 and shared their experiences of the SARS-CoV2 Diabetes is one of the major risk factors for fatal outcomes from COVID-19 Patients with diabetes are vulnerable to infection because of hyperglycemia;impaired immune function;vascular complications;and comorbidities such as hypertension, dyslipidemia, and cardiovascular disease In addition, angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV-2 in the human body Hence, the use of angiotensin-directed medications in patients with diabetes requires attention The severity and mortality from COVID-19 was significantly higher in patients with diabetes than in those without Thus, the patients with diabetes should take precautions during the COVID-19 pandemic Therefore, we review the current knowledge of COVID-19 including the global and regional epidemiology, virology, impact of diabetes on COVID-19, treatment of COVID-19, and standard of care in the management of diabetes during this critical period
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}